Crossmark

Novel insights into MSC-EVs therapy for immune diseases

Crossref DOI link: https://doi.org/10.1186/s40364-019-0156-0

Published Online: 2019-03-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lai, Peilong

Weng, Jianyu

Guo, Liyan

Chen, Xiaomei

Du, Xin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81671585, 81870121)

Science and Technology Planning Project of Guangzhou, China (201803040011 and 201803040005)
License Information

Text and Data Mining valid from 2019-03-18
More Information

Article History

Received: 1 December 2018

Accepted: 27 February 2019

First Online: 18 March 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.